Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2006-04-12
2008-10-07
Meller, Michael V (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Reexamination Certificate
active
07431948
ABSTRACT:
A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments relate to combinations of components, including at least one fraction isolated or derived from hops, tryptanthrin and conjugates thereof, rosemary, an extract or compound derived from rosemary, a triterpene species, or a diterpene lactone or derivatives or conjugates thereof.
REFERENCES:
patent: 3552975 (1971-01-01), Worden et al.
patent: 3720517 (1973-03-01), Bavisotto et al.
patent: 3932603 (1976-01-01), Haas
patent: 3933919 (1976-01-01), Wilkinson
patent: 3965188 (1976-06-01), Westermann et al.
patent: 4123561 (1978-10-01), Grant
patent: 4133903 (1979-01-01), Thiele et al.
patent: 4148873 (1979-04-01), Owades
patent: 4154865 (1979-05-01), Grant
patent: 4170638 (1979-10-01), Owades
patent: 4389421 (1983-06-01), Palamand
patent: 4401684 (1983-08-01), Versluys
patent: 4473551 (1984-09-01), Schinitsky
patent: 4554170 (1985-11-01), Panzer et al.
patent: 4644084 (1987-02-01), Cowles et al.
patent: 4692280 (1987-09-01), Spinelli
patent: 4767640 (1988-08-01), Goldstein et al.
patent: 4822607 (1989-04-01), Balassa et al.
patent: 4857554 (1989-08-01), Kallimanis
patent: 5006337 (1991-04-01), Motitschke et al.
patent: 5013571 (1991-05-01), Hay
patent: 5041300 (1991-08-01), Todd et al.
patent: 5073396 (1991-12-01), Todd, Jr.
patent: 5082975 (1992-01-01), Todd, Jr. et al.
patent: 5155276 (1992-10-01), Paul
patent: 5166449 (1992-11-01), Todd, Jr. et al.
patent: 5264236 (1993-11-01), Ogasahara et al.
patent: 5286506 (1994-02-01), Millis et al.
patent: 5296637 (1994-03-01), Stegink et al.
patent: 5387425 (1995-02-01), Hsu et al.
patent: 5604263 (1997-02-01), Tobe et al.
patent: 5641517 (1997-06-01), Eskeland et al.
patent: 5827895 (1998-10-01), Nutter et al.
patent: 5968539 (1999-10-01), Beerse et al.
patent: 6020019 (2000-02-01), Ting et al.
patent: 6129907 (2000-10-01), Sreenivasan et al.
patent: 6200594 (2001-03-01), Ernest et al.
patent: 6383527 (2002-05-01), Artman et al.
patent: 6391346 (2002-05-01), Newmark et al.
patent: 6440465 (2002-08-01), Meisner
patent: 6447762 (2002-09-01), Galcerá
patent: 6482456 (2002-11-01), Yokoo et al.
patent: 6583322 (2003-06-01), Shalai et al.
patent: 6801860 (2004-10-01), Dessen et al.
patent: 2002/0028852 (2002-03-01), Ghai et al.
patent: 2002/0076452 (2002-06-01), Babish et al.
patent: 2002/0077299 (2002-06-01), Babish et al.
patent: 2002/0086062 (2002-07-01), Kuhrts
patent: 2002/0086070 (2002-07-01), Kuhrts
patent: 2003/0077313 (2003-04-01), Schwartz et al.
patent: 2003/0096027 (2003-05-01), Babish et al.
patent: 2003/0113393 (2003-06-01), Babish et al.
patent: 2003/0133958 (2003-07-01), Kuno et al.
patent: 2004/0072900 (2004-04-01), Artman et al.
patent: 2004/0086580 (2004-05-01), Tripp et al.
patent: 2004/0137096 (2004-07-01), Kuhrts
patent: 2004/0219240 (2004-11-01), Babish et al.
patent: 2212148 (1972-09-01), None
patent: 3931147 (1991-03-01), None
patent: 19841615 (2000-03-01), None
patent: 63211219 (1988-09-01), None
patent: 4202138 (1992-07-01), None
patent: 6312924 (1994-11-01), None
patent: 07194351 (1995-08-01), None
patent: 8073369 (1996-03-01), None
patent: 409067245 (1997-03-01), None
patent: 10025247 (1998-01-01), None
patent: 10152428 (1998-06-01), None
patent: 2045955 (1995-10-01), None
patent: 1247011 (1986-07-01), None
patent: WO99/44623 (1999-09-01), None
patent: WO 00/68356 (2000-11-01), None
patent: WO00/74696 (2000-12-01), None
patent: WO02/02582 (2002-01-01), None
Science Direct, www.sciencedirect.com, Glucosamine:con or cure ?, 2007, 6 pages.
Provital Group, Rosemary-eco botany, 2007, 9 pages.
“Information on arthrotrimtm product”, downloaded from Internet Aug. 30, 2002.
“Information on Zyflamend and Zyflamend PM”, downloaded from Internet Aug. 30, 2002.
“Information on Hops and Beer Flavours”, downloaded from internet Feb. 15, 2005.
Anto, et al. Pharm. Pharmacol. Comm. 4:103-106 (1998).
Bermejo, et al. Rev. Esp. Enferm. Dig. 95: 621-624 and 625-628 (2003).
Brown, et al. J. Chem. Soc. 545 (1959).
Byrne, et al. J. Chem. Soc. (c):2810 (1971).
Carroccio, et al. Clin. Chem. 49:861-867 (2003).
Carson, j. Am. Chem. Soc. 73:1850-1851 (1951).
Chandra, et al. Indian J. Medical Research 60(1):138-142 (1972).
Charlier, et al. Eur. J. Med. Chem. 38:645-659 (2003).
Chou et al. Eur. J. Biochem. 115:207-216 (1981).
Chou, et al. Adv enzyme regul 22:27-55 (1984).
Chou, et al. J. Biol. Chem. 252:6438-6442 (1977).
Chou, et al. J. Theor. Biol. 35:285-297 (1972).
Chou, et al. Trends Pharm. Sci. 4:450-454 (1983).
Chou, j. Theor. Biol. 59:253-276 (1976).
Costa, et al. Digest. Liver Dis. 35:642-647 (2003).
Davis, WL. Abstract—Fertiliser, Feeding stuffs and Farm Supplies J. 11:694 (1926).
Ding, et al. Biochem. Biophy. Res. Comm. 261:218-223 (1999).
Friedman, et al. J Cutan Med. Surg. 6(5):449-459 (2002).
Germany, “The Absolutely German Drink,” contents of beer, 2004, 5 pages.
Goldstein, et al. Am. J. Gastroenterol. 96:1019-1027 (2001).
Halter, et al. Gut 49:443-453 (2001).
Hamberg, et al. J. Bio. Chem. 246:6713-6721 (1971).
Huang, et al. Cancer Res. 51:813-819 (1991).
International Search Report for PCT/US02/19617.
International Search Report for PCT/US04/16043.
Jach, Przegl Dermatol. 65(4):379-382 (1978).
Kanematsu, et al. J Bone Miner Res 12(11):1789-1796 (1997).
Lopes, Curr. Med Res Opin. 8:145-149 (1982).
Meling, et al. Scand. J. Gastroenterol. 31:339-344 (1996).
Noreen, et al. J. Nat. Prod 61:2-7 (1998).
Pairet, et al. Inflamm. Res 47, Supplement 2s93-s101 (1998).
Panglisch, Monafsschrift Fuer Brauwissen Schaft, 1990, 43(1), 4-16.
Pippa, et al. Scand. J. Gastroenterol. Suppl. 167:32-35 (1989).
Plewig, et al. J Invest. Dermatol. 65(6):532-536 (1975).
Poullis, et al. J. Gastroenterol. Hepatol. 18:756-762 (2003).
Ringbom, et al. J. Nat Prod 61:1212-1215 (1998).
Røseth, digest. Liver Dis. 35:607-609 (2003).
Schjerven, et al. Br. J. Dermatol. 149:484-491 (2003).
Shah, et al. Gut 48:339-346 (2001).
Shimamura, et al. Biochem. Biophys. Res. Comm. 289:220-224 (2001).
Shureiqi, et al. Cancer Res. 61:6307-6312 (2001).
Sivri, fundam. Clinic. Pharmacol. 18:23-31 (2004).
Subbaramaiah, et al. Cancer Res. 60:2399-2404 (2000).
Suh, et al. Cancer Res. 58:717-723 (1988).
Tagashira, et al., Biosci. Biotech. Biochem. 59(4):740-742 (1996).
Thomas m. Newmark and paul schulick, Beyond Aspirin nature's answer to arthritis, cancer & alzheimer's disease, hohm press (2000) release 7; pp. 147-151, 248.
Tibble, et al. Drugs Today 37:85-96 (2001).
Tibble, et al. Gut 45:362-366 (1999).
Tobe, et al. Biosci. Biotech. Biochem 61(1):158-159 (1997).
Wang, et al. Free Radical Biology & Medicine 27:612-616 (1999).
Warner, et al. Proc Natl Acad Sci USA 96:7563-7568 (1999).
Yamamoto, et al. Abstract—Prostaglandins & Other Lipid Mediators 59:1-235 (1999).
Yamamoto, FEBS Letters 465:103-106 (2000).
Yui, et al. Biol. Pharm. Bull. 26:753-760 (2003).
Babish John G.
Bland Jeffrey S.
Darland Gary K.
Howell Terrence
Lerman Robert
McDermott Will & Emery LLP
Meller Michael V
Metaproteomics, LLC
LandOfFree
Compositions that treat or inhibit pathological conditions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions that treat or inhibit pathological conditions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions that treat or inhibit pathological conditions... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4017745